Botanical species · safety record

Hyoscyamus niger

The EFSA Compendium of Botanicals holds 4 constituent measurements and 1 adverse-effect record for Hyoscyamus niger. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Hyoscyamus niger L.

4Constituent measurements
1Safety records
2Cited sources
68Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 68 licensed products naming Hyoscyamus niger as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Fresh whole flowering plant
  • Leaf
  • Plant in bloom
  • Tincture of the entire flowering plant
  • Whole flowering plant
  • Whole flowering plant(s)
  • Whole fresh flowering plant
  • Whole fresh flowering plant(s)

What the records describe

Constituents measured

  • Alkaloids1
  • Lignans1
  • Saponins1
  • Tropane alkaloids1

Plant parts

  • Seed3
  • Live plants1

Preparations

  • Solvent extraction4

Effect types

  • Neurotoxicity1

Target tissues

  • Neurologic: central nervous system1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsSeedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
LignansSeedSolvent extractionUnspecifiedNo resolvable identifier
SaponinsSeedSolvent extractionUnspecifiedNo resolvable identifier
Tropane alkaloidsLive plantsSolvent extractionUnspecifiedNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
NeurotoxicityNeurologic: central nervous systemHuman (as organism)Case reportNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Alizadeh, Anahita., Moshiri, Mohammad., Alizadeh, Javad., Balali-Mood, Mahdi. Black henbane and its toxicity - a descriptive review.. Avicenna journal of phytomedicine, 2014, vol. 4, no. 5, p. 297-311.
  2. Ma, CY., Liu, WK., Che, CT. Lignanamides and nonalkaloidal components of Hyoscyamus niger seeds. Journal of natural products, 2002, vol. 65, no. 2, p. 206-209. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue